- Home
- SSTI vs KZIA Comparison
SSTI vs KZIA Comparison
Compare SSTI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTI | KZIA |
|---|---|---|
| Founded | 1996 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.1M | 74.1M |
| IPO Year | 2017 | 2002 |
Fundamental Metrics
Financial Performance| Metric | SSTI | KZIA |
|---|---|---|
| Price | $7.30 | $8.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $15.80 | ★ $17.67 |
| AVG Volume (30 Days) | ★ 223.3K | 194.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,753,000.00 | N/A |
| Revenue This Year | $3.98 | N/A |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | N/A |
| 52 Week Low | $5.78 | $0.64 |
| 52 Week High | $18.65 | $17.40 |
Technical Indicators
Market Signals| Indicator | SSTI | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 64.10 |
| Support Level | $5.81 | $5.64 |
| Resistance Level | $7.73 | $8.94 |
| Average True Range (ATR) | 0.54 | 0.78 |
| MACD | 0.04 | 0.41 |
| Stochastic Oscillator | 44.49 | 85.66 |
Price Performance
Historical ComparisonAbout SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.